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INTRODUCTION
The recent pandemic caused by the novel human coronavirus (CoV), currently referred to
as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which is responsible
for COronaVIrus Disease 2019 (COVID-19), is leading to alarmism among pet owners as a
consequence of few case reports of SARS-CoV-2 infection in dogs and cats. COVID-19 emerged
in December 2019 in Wuhan City, Hubei Province, China, in humans exposed to wildlife at the
Huanan seafood wholesale market, the largest seafood market in central China. This is a typical
Asian wet market, where different species of farm and wild animals are commonly sold dead and
live. The blood and other body fluids originating from these animals represent an exceptional
source for the spillover of animal viruses (1).
SARS-CoV-2 recognizes a probable zoonotic origin, since the virus likely descends from a
bat betacoronavirus, strictly related to the one responsible for the 2002–2003 SARS epidemic
(SARS-CoV), which was transmitted to humans directly or through previous adaptation to a not
yet identified intermediate host (1, 2). After this adaptation to the new host, the virus was able to
spread to the human population through a human-to-human transmission, without any further
role of animals in the epidemiological chain. However, pets have been alternatively brought into
play as a possible source of infection for humans, intermediate hosts for SARS-CoV-2 transmission
to humans or hosts of animal CoVs that may cross-protect humans against the highly pathogenic
CoV. The aim of this opinion article is to define the role of dogs and cats in the SARS-CoV-2
epidemiology in the light of current knowledge.
CAN DOGS AND CATS BE INFECTED BY SARS-CoV-2?
To date, sporadic cases of SARS-CoV-2 infection have been reported in dogs and cats. The first
animal cases involved 2 dogs, a 17-year-old Pomeranian dog and a 2-year-old German shepherd,
living in Hong Kong and in close contact with SARS-CoV-2 infected human patients (3). The
animals did not display any clinical signs related to the infection and they shed, in their respiratory
secretions, low SARS-CoV-2 loads asmeasured by real-time RT-PCR, amolecular tool able to detect
even traces of viral RNA. Accordingly, a mixed breed dog living with the infected German shepherd
(that also developed antibodies against SARS-CoV-2) has remained uninfected. Unfortunately, the
Pomeranian dog died a few days after repeatedly testing negative for SARS-CoV-2 and the owner
declined any necropsy, but the cause of death was clearly associated to the previous heart and
kidney disease affecting this old animal. A third SARS-CoV-2 positive dog was later reported in
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North Carolina, USA. The infected pug displayed mild
respiratory signs (sneeze and cough) and was living in a highly
contaminated household, where 3 family members tested positive
for SARS-CoV-2. The family participated in a study at Duke
University that involved testing family members and their pets
for COVID-191. However, the United States Department of
Agriculture’s National Veterinary Services Laboratories were
unable to confirm the positive testing of this pug. The first
confirmed case of SARS-CoV-2 infection in a pet dog in the
United States was then reported in a German shepherd in the
State of New York2.
A greater concern was, on the other hand, generated by the
involvement of cats. The first case occurred in a cat in Brussels
whose owner had just returned from a vacation in Italy (4).
The cat developed a gastroenteric disease. It shed discrete SARS-
CoV-2 titres in the vomit and, to a lesser extent in the feces.
To date, whether the observed clinical signs were associated
with SARS-CoV-2 infection is unknown. Another SARS-CoV-
2 infected cat was reported in Hong Kong. The pet was living
with an infected human patient and did not display any clinical
signs, but the virus was detected in its respiratory secretions
and feces3. Two cats living in two separate areas of the State
of New York and having mild respiratory illness tested SARS-
CoV-2 positive. The first cat was tested after it showed mild
respiratory signs, but no individuals in the household were
confirmed to be ill with COVID-19. The source of infection of
the cat might have been the contact with an infected human
inside or outside its household. The second cat showed signs
of respiratory illness after its owner tested positive for COVID-
19. Both animals fully recovered from the respiratory disease (5).
Sporadic cases of SARS-CoV-2 natural infection in dogs and cats
were reported throughout the world (6). A high prevalence of
PCR positive testing was reported in cats in Hong Kong, with
6 cases (out of 50 quarantined animals from COVID-19 positive
households) of apparent human-to-feline transmission involving
healthy cats (7).
To date, despite these few reports of SARS-CoV-2 infections
in pets, there is some evidence that cats may be more susceptible
than dogs to this highly pathogenic human CoV. SARS-CoV-2
is strictly related to SARS-CoV at genetic and biological levels,
being included in the same viral species, Severe acute respiratory
syndrome-related coronavirus (subgenus Sarbecovirus, genus
Betacoronavirus) and sharing the same cellular receptor, the
angiotensin converting enzyme type 2 (ACE2) (8). SARS-CoV-
2 infected cats both through the natural and the experimental
routes. Several cats of the Amoy Gardens in Hong Kong, where
1CNN. A Pug in North Carolina May be the First Dog in US to Test Positive
for Coronavirus. Available online at: https://time.com/5828413/dog-coronavirus/
(accessed April 30, 2020).
2Confirmation of COVID-19 in Pet Dog in New York USDA Animal and
Plant Health Inspection Service sent this bulletin at 06/02/2020 04:10 PM
EDT. Available online at: https://content.govdelivery.com/accounts/USDAAPHIS/
bulletins/28ead4f (accessed December 14, 2020).
3South China Morning Post. Coronavirus: Pet Cat in Hong Kong Tests Positive
After Owner Becomes Infected. Available online at: https://www.scmp.com/news/
hong-kong/health-environment/article/3077802/coronavirus-pet-cat-hong-
kong-tests-positive (accessed April 18, 2020).
more than 100 infected people were living, were found to be
positive for SARS-CoV4 and the experimental administration
of this virus resulted in a productive infection with shedding
of high viral loads and virus transmission to in-contact cats
(9). In-silico analysis of the feline and ferret ACE2 has shown
that SARS-CoV-2 can bind with high efficiency to the receptors
of these animals (10). Dogs experimentally inoculated with
SARS-CoV-2 developed a mild infection and shed low titres of
viral RNA. In contrast, experimentally-infected cats and ferrets
appeared to be highly susceptible to SARS-CoV-2, shedding
high amounts of virus and infecting (few) in-contact animals
(11). A serological survey was conducted in cats in Wuhan
(China), the epicenter of the CoV pandemic, between January
and March 2020. Fifteen out of 102 cats tested positive by
an ELISA using the receptor-binding domain (RBD) of the
spike protein, and 11 of these positivities were confirmed
by virus neutralization. Most of the seropositive animals had
been in close contact with SARS-CoV-2 infected humans
(12). In a large-scale study assessing SARS-CoV-2 infection
in 919 companion animals living in northern Italy, sampled
at a time of frequent human infection, none of these pets
tested PCR positive. However, 3.3% of dogs and 5.8% of cats
had measurable SARS-CoV-2 neutralizing antibody titres; dogs
from COVID-19 positive households were significantly more
likely to test positive than those from COVID-19 negative
households (13). Higher seroprevalence rates for SARS-CoV-
2, ranging from 21 to 53% depending of the test used, were
observed in domestic carnivores from COVID-19 positive
household in two French regions (14). On the contrary, no
SARS-CoV-2 antibodies nor viral RNA were detected in 21
domestic pets (9 cats and 12 dogs) living in close contact
with a veterinary community with some COVID-19 positive
students (15).
ARE DOGS INVOLVED IN SARS-CoV-2
EMERGENCE?
A recent paper has suggested the dog as an intermediate host for
SARS-CoV-2 adaptation and transmission to humans (16). The
hypothesis is based on the low frequency of CG dinucleotides
(CpG) in the SARS-CoV-2 genome, which was much lower with
respect to other betacoronaviruses, but similar to that observed
in the canine alphacoronavirus (CCoV), with particular regards
to that of a hypervirulent strain (pantropic CCoV) first detected
in Italy (17, 18), and later reported in other countries (19, 20).
The reduced number of CpGs may represent a pathogenicity
marker, since these dinucleotides are the target for a cellular
antiviral protein, the zinc finger antiviral protein (ZAP). ZAP
binds specifically to CpG dinucleotides in viral RNA genomes
via its RNA-binding domain, thus inhibiting viral replication
and mediating viral genome degradation. As a consequence, a
lower CpG content in the viral genome is associated with a
greater ZAP resistance and higher virulence. A further hypothesis
4World Health Organization. Consensus Document on the Epidemiology of Severe
Acute Respiratory Syndrome (SARS). Available online at: https://apps.who.int/iris/
handle/10665/70863 (accessed April 18, 2020).
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of the same study is that SARS-CoV-2 was originally an
enteric virus, since the enteric environment seems to be more
favorable to the selection of viruses with low CpG content and
indeed CCoV, the canine low CpG content alphacoronavirus,
replicates in the gut mucosa (21). Accordingly, a number of
human patients with COVID-19 display intestinal symptoms
(22). Certainly, the possible role of dogs as intermediate hosts
is a fascinating hypothesis, but at the moment it appears just
a speculation lacking any robust scientific evidence. A snake
origin of the virus was suggested on the basis of the codon
usage bias of SARS-CoV-2 that seemed to be more suitable
for the transcription machinery of reptiles (23). However, this
hypothesis was subsequently rebutted due to the lack of robust
data (8).




Dogs and cats have their own CoVs, which are genetically
and biologically divergent from SARS-CoV-2 and do not infect
humans (8). Two CoVs are currently circulating in dogs. The
enteric alphacoronavirus CCoV forms a unique viral species
along with transmissible gastroenteritis virus of swine (TGEV)
and feline coronavirus (FCoV). The betacoronavirus canine
respiratory coronavirus (CRCoV) is closely related to bovine
coronavirus (BCoV) and to a low-pathogenic betacoronavirus
of humans, HCoV-OC43 (8). CCoV includes two genotypes,
CCoV-I and II. The latter consists of two subgenotypes, CCoV-
IIa and IIb, which are represented by classical and recombinant
TGEV-like strains, respectively (24, 25). Hypervirulent strains
belong to subtype CCoV-IIa (6). In cats two genotypes (FCoV-
I and FCoV-II) are known, both including two different
pathotypes, namely the feline enteric coronavirus and the
feline infectious peritonitis virus. The former is responsible for
asymptomatic infections or mild, self-limiting enteritis while the
latter causes a systemic, fatal disease known as feline infectious
peritonitis (8). An Italian study, based on computational analysis
of full-length CoV genomes, has recently identified some
immunorelevant epitopes in the RBD of the spike protein, which
seem to be conserved between SARS-CoV-2 and some animal
betacoronaviruses, mainly BCoV and CRCoV (26). According
to the authors’ hypothesis, repeated exposure to these animal
CoVs may have partially immunized people against SARS-
CoV-2. This hypothesis is fascinating but needs to be further
investigated. A recent study has demonstrated that humans
previously exposed to other antigenically distinct common
seasonal HCoVs could have non-neutralizing antibodies that
cross-reacted with SARS-CoV-2. These antibodies were not
associated with protection against SARS-CoV-2 infections or
hospitalizations, but paradoxically they were boosted upon
SARS-CoV-2 infection (27).
However, the presence of poorly cross-reacting antibodies
may instead trigger an antibody-dependent enhancement
favoring the entry into the host cells of viral particles bound
to cytophilic antibodies (28). Similar protection against or
exacerbation of COVID-19 should have been elicited by
HCoV-OC43, a low pathogenic betacoronavirus that has been
circulating in humans for more than a century (8). Therefore,
in this case also, stronger scientific evidence is needed to
confirm the hypothesis suggested on the basis of a raw
bioinformatics analysis.
DISCUSSION
To date (December 14, 2020), no pet-to-human transmission
of the virus has been reported during this phase of the
pandemic and although more than 71 million humans in
the world tested positive for SARS-CoV-2 (https://www.ecdc.
europa.eu/en/geographical-distribution-2019-ncov-cases), there
are only sporadic cases of natural infections known in dogs
and cats. Therefore, according to the present knowledge, the
fact that SARS-CoV-2 can sporadically infect some domestic
carnivores does not imply that pets play an active role in the
virus transmission to humans. However, there is increasing
evidence that, albeit with different ranges of susceptibility,
dogs and cats can be infected as a consequence of close
contact with SARS-CoV-2 positive people. In this scenario,
dogs and cats act as (often asymptomatic) victims of a
human-to-pet transmission rather than the source of infection
for human beings.
In addition, studies that rely only on bioinformatic
and computational analyses of viral genomes, mRNAs and
proteins may outline interesting scenarios about SARS-CoV
origin, epidemiology and pathobiology, but they need to
be supported by more comprehensive in-vitro and in-
vivo investigations. Accordingly, taking into account the
scientific evidence supporting the current knowledge, dogs
and cats are unlikely to play any role in the emergence
and/or transmission to humans of this pandemic virus. Only
extensive epidemiological investigations in dogs and cats
living in geographic areas with high prevalence of SARS-
CoV-2 in humans can definitively clarify their role in the
transmission of the virus. In addition, more comprehensive
seroepidemiological studies in veterinarians, pet owners
and breeders should assess whether these population
groups are either (partially) protected from COVID-19 or
susceptible to a more severe course of SARS-CoV-2 infection.
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